Literature DB >> 17454443

Glial activation and matrix metalloproteinase release in cerebral malaria.

A Szklarczyk1, M Stins, E A Milward, H Ryu, C Fitzsimmons, D Sullivan, K Conant.   

Abstract

Although neurological symptoms associated with cerebral malaria (CM) are largely reversible, recent studies suggest that lasting neurological sequelae can occur. This may be especially true for children, in whom persistent deficits include problems with memory and attention. Because the malaria parasite is not thought to enter the brain parenchyma, lasting deficits are likely related to factors including the host response to disease. Studies with a rodent model, and with human postmortem tissue, suggest that glial activation occurs with CM. In this review, the authors will highlight studies focused on such activation in CM. Likely causes will be discussed, which include ischemia and activation of blood brain barrier endothelial cells. The potential consequences of glial activation will also be discussed, highlighting the possibility that glial-derived proteinases contribute to structural damage of the central nervous system (CNS). Of note, for the purposes of this focused review, glial activation will refer to the activation of astrocytes and microglial cells; discussion of oligodendroglial cells will not be included. In addition, although events thought to be critical to the pathogenesis of CM and glial activation will be covered, a comprehensive review of cerebral malaria will not be presented. Excellent reviews are already available, including Coltel et al (2004; Curr Neurovasc Res 1: 91-110), Medana and Turner (2006; Int J Parasitol 36: 555-568), and Hunt et al (2006; Int J Parasitol 36: 569-582).

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17454443     DOI: 10.1080/13550280701258084

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  87 in total

1.  Identification of novel matrix metalloproteinase-7 (matrilysin) cleavage sites in murine and human Fas ligand.

Authors:  Tracy Vargo-Gogola; Howard C Crawford; Barbara Fingleton; Lynn M Matrisian
Journal:  Arch Biochem Biophys       Date:  2002-12-15       Impact factor: 4.013

2.  Pro-apoptotic signaling pathway activated by echistatin in GD25 cells.

Authors:  Elena Alimenti; Simona Tafuri; Antonio Scibelli; Danila D'Angelo; Laura Manna; Luigi Michele Pavone; M Antonietta Belisario; Norma Staiano
Journal:  Biochim Biophys Acta       Date:  2004-07-23

3.  A role for Fas-Fas ligand interactions during the late-stage neuropathological processes of experimental cerebral malaria.

Authors:  Sarah M Potter; Tailoi Chan-Ling; Emilia Rosinova; Helen J Ball; Andrew J Mitchell; Nicholas H Hunt
Journal:  J Neuroimmunol       Date:  2006-01-18       Impact factor: 3.478

4.  Compromised blood-nerve barrier, astrogliosis, and myelin disruption in optic nerves during fatal murine cerebral malaria.

Authors:  N Ma; M C Madigan; T Chan-Ling; N H Hunt
Journal:  Glia       Date:  1997-02       Impact factor: 7.452

Review 5.  Cerebral malaria.

Authors:  G Turner
Journal:  Brain Pathol       Date:  1997-01       Impact factor: 6.508

6.  Matrix metalloproteinase-3 removes agrin from synaptic basal lamina.

Authors:  M VanSaun; M J Werle
Journal:  J Neurobiol       Date:  2000-05

Review 7.  Macrophages/microglial cells in patients with cerebral malaria.

Authors:  Martin H Deininger; Peter G Kremsner; Richard Meyermann; Hermann Schluesener
Journal:  Eur Cytokine Netw       Date:  2002 Apr-Jun       Impact factor: 2.737

8.  Activation of matrix metalloproteinase-3 and agrin cleavage in cerebral ischemia/reperfusion.

Authors:  Sònia Solé; Valérie Petegnief; Roser Gorina; Angel Chamorro; Anna M Planas
Journal:  J Neuropathol Exp Neurol       Date:  2004-04       Impact factor: 3.685

9.  Regulation of insulin-like growth factor (IGF)-I action by matrix metalloproteinase-3 involves selective disruption of IGF-I/IGF-binding protein-3 complexes.

Authors:  John L Fowlkes; Delila M Serra; R Clay Bunn; Kathryn M Thrailkill; Jan J Enghild; Hideaki Nagase
Journal:  Endocrinology       Date:  2003-11-06       Impact factor: 4.736

10.  Generation of biologically active IL-1 beta by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1 beta processing.

Authors:  U Schönbeck; F Mach; P Libby
Journal:  J Immunol       Date:  1998-10-01       Impact factor: 5.422

View more
  14 in total

Review 1.  Peroxisome proliferator activating receptor (PPAR) in cerebral malaria (CM): a novel target for an additional therapy.

Authors:  S Balachandar; A Katyal
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-12-09       Impact factor: 3.267

2.  A noncanonical autophagy is involved in the transfer of Plasmodium-microvesicles to astrocytes.

Authors:  Inès Leleu; Delphine Genete; Sophie Salomé Desnoulez; Nasreddine Saidi; Priscille Brodin; Frank Lafont; Stanislas Tomavo; Sylviane Pied
Journal:  Autophagy       Date:  2021-11-06       Impact factor: 13.391

3.  Structure-activity relationship and mechanism of action studies of manzamine analogues for the control of neuroinflammation and cerebral infections.

Authors:  Jiangnan Peng; Sucheta Kudrimoti; Sivaprakasam Prasanna; Srinivas Odde; Robert J Doerksen; Hari K Pennaka; Yeun-Mun Choo; Karumanchi V Rao; Babu L Tekwani; Vamsi Madgula; Shabana I Khan; Bin Wang; Alejandro M S Mayer; Melissa R Jacob; Lan Chun Tu; Jürg Gertsch; Mark T Hamann
Journal:  J Med Chem       Date:  2010-01-14       Impact factor: 7.446

Review 4.  Microglia in infectious diseases of the central nervous system.

Authors:  Monica M Mariani; Tammy Kielian
Journal:  J Neuroimmune Pharmacol       Date:  2009-09-02       Impact factor: 4.147

5.  Matrix Metalloproteinase-9 and Haemozoin: Wedding Rings for Human Host and Plasmodium falciparum Parasite in Complicated Malaria.

Authors:  Mauro Prato; Giuliana Giribaldi
Journal:  J Trop Med       Date:  2011-05-26

6.  The Case for the Use of PPARγ Agonists as an Adjunctive Therapy for Cerebral Malaria.

Authors:  Lena Serghides
Journal:  PPAR Res       Date:  2011-06-09       Impact factor: 4.964

7.  New biomarkers for stage determination in Trypanosoma brucei rhodesiense sleeping sickness patients.

Authors:  Natalia Tiberti; Enock Matovu; Alexandre Hainard; John Charles Enyaru; Veerle Lejon; Xavier Robin; Natacha Turck; Dieudonné Mumba Ngoyi; Sanjeev Krishna; Sylvie Bisser; Bertrand Courtioux; Philippe Büscher; Krister Kristensson; Joseph Mathu Ndung'u; Jean-Charles Sanchez
Journal:  Clin Transl Med       Date:  2013-01-07

8.  Perivascular Arrest of CD8+ T Cells Is a Signature of Experimental Cerebral Malaria.

Authors:  Tovah N Shaw; Phillip J Stewart-Hutchinson; Patrick Strangward; Durga B Dandamudi; Jonathan A Coles; Ana Villegas-Mendez; Julio Gallego-Delgado; Nico van Rooijen; Egor Zindy; Ana Rodriguez; James M Brewer; Kevin N Couper; Michael L Dustin
Journal:  PLoS Pathog       Date:  2015-11-12       Impact factor: 6.823

9.  Natural haemozoin induces expression and release of human monocyte tissue inhibitor of metalloproteinase-1.

Authors:  Manuela Polimeni; Elena Valente; Daniela Ulliers; Ghislain Opdenakker; Philippe E Van den Steen; Giuliana Giribaldi; Mauro Prato
Journal:  PLoS One       Date:  2013-08-14       Impact factor: 3.240

10.  Host matrix metalloproteinases in cerebral malaria: new kids on the block against blood-brain barrier integrity?

Authors:  Manuela Polimeni; Mauro Prato
Journal:  Fluids Barriers CNS       Date:  2014-01-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.